全文获取类型
收费全文 | 9401篇 |
免费 | 1038篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 332篇 |
妇产科学 | 153篇 |
基础医学 | 1318篇 |
口腔科学 | 376篇 |
临床医学 | 1090篇 |
内科学 | 1858篇 |
皮肤病学 | 151篇 |
神经病学 | 628篇 |
特种医学 | 406篇 |
外科学 | 1423篇 |
综合类 | 246篇 |
一般理论 | 6篇 |
预防医学 | 900篇 |
眼科学 | 234篇 |
药学 | 685篇 |
中国医学 | 3篇 |
肿瘤学 | 582篇 |
出版年
2021年 | 101篇 |
2020年 | 73篇 |
2019年 | 109篇 |
2018年 | 162篇 |
2017年 | 166篇 |
2016年 | 162篇 |
2015年 | 191篇 |
2014年 | 208篇 |
2013年 | 345篇 |
2012年 | 399篇 |
2011年 | 409篇 |
2010年 | 304篇 |
2009年 | 286篇 |
2008年 | 338篇 |
2007年 | 396篇 |
2006年 | 389篇 |
2005年 | 398篇 |
2004年 | 326篇 |
2003年 | 363篇 |
2002年 | 324篇 |
2001年 | 265篇 |
2000年 | 289篇 |
1999年 | 258篇 |
1998年 | 192篇 |
1997年 | 188篇 |
1996年 | 183篇 |
1995年 | 151篇 |
1994年 | 172篇 |
1993年 | 122篇 |
1992年 | 208篇 |
1991年 | 195篇 |
1990年 | 175篇 |
1989年 | 194篇 |
1988年 | 184篇 |
1987年 | 182篇 |
1986年 | 164篇 |
1985年 | 182篇 |
1984年 | 126篇 |
1983年 | 113篇 |
1982年 | 93篇 |
1981年 | 86篇 |
1980年 | 75篇 |
1979年 | 115篇 |
1978年 | 75篇 |
1977年 | 83篇 |
1976年 | 71篇 |
1973年 | 86篇 |
1972年 | 74篇 |
1971年 | 73篇 |
1970年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
1.
2.
3.
4.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
5.
6.
The MMPI was administered during the patient-perceived best time of the menstrual cycle and during the patient-perceived worst time of the cycle in order to examine the stability of MMPI profile configurations. Subjects were 214 women who were referred to two metropolitan outpatient premenstrual syndrome (PMS) clinics for moderate to severe premenstrual complaints. This sample was selected from 1,849 intake files after screening by strict selection criteria for PMS. The results indicate that there are wide fluctuations in profile patterns between the best and worst times of the menstrual cycle for a large number of patients. Caution in using the MMPI is strongly advised. 相似文献
7.
8.
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies
Bayard L. Powell Hyman B. Muss Robert L. Capizzi Mary E. Caponera Douglas R. White Patricia J. Zekan James N. Atkins Don V. Jackson Jr. Frederick Richards II John B. Craig Julia M. Cruz Charles L. Spurr 《Cancer chemotherapy and pharmacology》1987,19(3):250-252
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182 相似文献
9.
10.
J. Duteil FA Rambert AM Pointeau P. Mangiameli and E. Assous 《Fundamental & clinical pharmacology》1991,5(8):695-708
The potential antidepressant effect of flerobuterol (dl-(fluoro-2 phenyl)-1 t-butylamino-2 ethanol), a new drug related to beta-adrenoceptor agonists, was evaluated and compared with imipramine and salbutamol using classical psychopharmacological tests in mice. Like imipramine and salbutamol, flerobuterol (0.5-32 mg kg-1, ip) fully prevented apomorphine (16 mg kg-1, sc)- and partly reversed reserpine- and oxotremorine-induced hypothermia. At higher doses (16-32 mg kg-1), flerobuterol enhanced the toxic effects of yohimbine. Unlike imipramine, flerobuterol and salbutamol did not reduce immobility duration in the behavioural despair test. Salbutamol and flerobuterol decreased locomotor activity. Flerobuterol did not induce mydriasis, did not prevent oxotremorine-induced tremors or salivary and lacrimal gland secretion and did not reduce reserpine-induced palpebral ptosis. Propranolol (8 mg kg-1, ip) but not alpha-methyl-paratyrosine (75 mg kg-1, ip) prevented the flerobuterol-induced antagonism of apomorphine-induced hypothermia. Our results suggest that flerobuterol demonstrates potential antidepressant activity, which could be related to beta-adrenoceptor activation in mice. 相似文献